Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 447

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 447
---
 Non-Equity     
 Incentive Plan 
 Compensation   
 ($)            |     | All Other    
 Compensation 
 ($)          |     |   Total 
     ($) |
| Ben Hwang                            |     | 2023 |     | 470,000 |     | —     |     | —      |     | —      |     | —              |     | —            |     | 470,000 |
| Chief Executive Officer and Chairman |     | 2022 |     | 470,000 |     | —     |     | —      |     | —      |     | —              |     | —            |     | 470,000 |

Outstanding Equity Awards at 2023 Fiscal Year-End As of December 31, 2023, Dr. Hwang did not hold any outstanding equity awards with respect to Profusa.

253 Additional Narrative Disclosure Severance Arrangements Profusa generally executes an offer of employment before an executive joins Profusa. This offer describes the basic terms of the executive’s employment, including his or her start date, starting salary, annual incentive target (if any) and equity awards. Profusa does not maintain a general severance policy. However, Dr. Hwang’s offer letter, dated January 1, 2013, provides that, upon a termination of employment by Profusa without cause, Profusa will pay him six months’ base salary plus a pro -rataportion of any earned bonus payment (in a lump sum payment), as well as pay his monthly COBRA premiums for up to six months, subject to Dr. Hwang’s execution of a release of claims in favor of Profusa. 401(k) Plan Profusa maintains a qualified 401(k) savings plan which allows participants to defer a portion of their compensation to the 401(k) savings plan on a before -taxand after -taxbasis. Profusa provides discretionary profit sharing contributions on behalf of its eligible participants. Profusa did not make any profit sharing contributions in 2023. Director Compensation Profusa’s historical director compensation program has consisted of equity awards. However, in 2023, Profusa did not grant any equity awards to its non -employeedirectors and did not pay any cash director fees or other compensation to its non -employeedirectors. As of December 31, 2023, the non -employeedirectors held outstanding options to purchase Profusa shares as follows: Joan Braddi — 80,000shares. As Prof